Recombinant IL-12, IL-23 (Ustekinumab Biosimilar) antibody

Catalog No. ABIN7538048

This Human Monoclonal antibody specifically detects IL-12, IL-23 (Ustekinumab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL-12, IL-23 (Ustekinumab Biosimilar) antibody (ABIN7538048)

Target: IL-12, IL-23 (Ustekinumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL-12, IL-23 (Ustekinumab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-IL-12, IL-23 (Ustekinumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Ustekinumab Biosimilar - Anti-Human IL-12 IL-23 mAb - Research Grade

Characteristics: Antibody Type: Human IgG1 kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: 4 °C,-20 °C

Storage Comment: 4°C for short term, -20°C for long term

Target Details for IL-12, IL-23 (Ustekinumab Biosimilar)

Target: IL-12, IL-23 (Ustekinumab Biosimilar)

Target Type: Biosimilar

Background: Ustekinumab is a human monoclonal antibody used to treat psoriasis. It is also approved to treat Crohn’s disease and ulcerative colitis among people who have not responded to more traditional treatments. It is a subcutaneous human interleukin 12 and interleukin 23 antagonist. These are naturally occurring proteins that regulate the immune system and immune-mediated inflammatory disorders.

Molecular Weight: 148 kDa

CAS-No: 815610-63-0